Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Which Psychedelic Drug Stock Category Outperformed This Past Week?
Article By:
Lorimer Wilson
Sunday, August 15, 2021 6:00 AM EDT
Which has performed best lately, the Pure-Play Marijuana Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index?
Marijuana Drug Stocks: All You Need To Know
Article By:
Lorimer Wilson
Friday, August 13, 2021 4:53 AM EDT
Eight clinical-stage companies are researching the treatment of a wide variety of illnesses using marijuana. Six have market capitalizations between $50M and $500M; two are between $37M-$50M.
Cannabis-Centric Bio-Pharma Stocks Category Declined Almost 3% This Past Week
Article By:
Lorimer Wilson
Sunday, April 25, 2021 3:00 AM EDT
Introducing our new Cannabis-Centric Bio-Pharma Stocks Index of the 13 clinical-stage biopharmaceutical companies involved exclusively in the development of drugs using CBD and THC.
Traumatic Brain Injury: Six Psychedelics Companies Target $120 Billion Market
Thanks for sharing: RVV mentioned in article: "Revive Therapeutics (CAN: RVV / US: $RVVTF) plans to seek IND status from the FDA in Q2 2021, for its psilocybin-based research on TBI. With a different (non-psychedelic) drug already in a Phase III clinical trial, Revive has more experience in formal clinical research. But TBI is not the principal focus of its R&D."